Patent · US Active

Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt

US9994579B2 · kind B2 · utility

3Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 11, 2015
Grant dateJun 12, 2018
Priority date
Expiry dateDec 11, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to novel crystalline forms of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-car boxylic acid dimethylamide(compound I), its salts, and process for preparation thereof. Crystalline forms in the present invention have good stability, low hygroscopicity, good processability, easy treatability and other favorable properties. In addition, the process is simple, low cost, and has an important value for future optimization and development of the drug.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.